Retrospective study assesses treatment outcomes in classical hairy cell leukaemia, suggesting effective use of BRAF inhibitors with rituximab.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tauveron‐Jalenques et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: